Pharmacovigilance Raised As Part Of GDUFA III

GDUFA III May Be Opportunity For Proactive Pharmacovigilance Discussions

Blister Packs
FDA and sponsors may be interested in increasing communications related to generic drug pharmacovigilance activities • Source: Shutterstock

More from Regulation

More from Policy & Regulation